BMC Pediatrics (Jul 2018)

The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol

  • Thomas Waterfield,
  • Mark D. Lyttle,
  • Derek Fairley,
  • James Mckenna,
  • Kerry Woolfall,
  • Fiona Lynn,
  • Julie-Ann Maney,
  • Damian Roland,
  • Aoife Weir,
  • Michael D. Shields,
  • on behalf of Paediatric Emergency Research in the UK and Ireland (PERUKI)

DOI
https://doi.org/10.1186/s12887-018-1220-x
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septicaemia. A paucity of definitive diagnostic testing creates diagnostic uncertainty for clinicians; a safe approach mandates children without invasive disease are often admitted and treated with broad-spectrum antibiotics. Conversely, a cohort of children still experience significant mortality and morbidity due to late diagnosis. Current management is based on evidence which predates (i) the introduction of meningococcal B and C vaccines and (ii) availability of point of care testing (POCT) for procalcitonin (PCT) and Neisseria meningitidis DNA. Methods This PiC study is a prospective diagnostic accuracy study evaluating (i) rapid POCT for PCT and N. meningitidis DNA and (ii) performance of existing clinical practice guidelines (CPG) for feverish children with non-blanching rash. All children presenting to the ED with a history of fever and non-blanching rash are eligible. Children are managed as normal, with detailed prospective collection of data pertinent to CPGs, and a throat swab and blood used for rapid POCT. The study is running over 2 years and aims to recruit 300 children. Primary objective:Report on the diagnostic accuracy of POCT for (i) N. meningitidis DNA and (ii) PCT in the diagnosis of early MDReport on the diagnostic accuracy of POCT for PCT in the diagnosis of Invasive bacterial infection Secondary objectives:Evaluate the performance accuracy of existing CPGsEvaluate cost-effectiveness of available diagnostic testing strategiesExplore views of (i) families and (ii) clinicians on research without prior consent using qualitative methodologyReport on the aetiology of NBRs in children with a feverish illness Discussion The PiC study will provide important information for policy makers regarding the value of POCT and on the utility and cost of emerging diagnostic strategies. The study will also identify which elements of existing CPGs may merit inclusion in any future study to derive clinical decision rules for this population. Trial registration NCT03378258. Retrospectively registered on December 19, 2017.

Keywords